Welcome to LookChem.com Sign In|Join Free

CAS

  • or

1482-51-5

Post Buying Request

1482-51-5 Suppliers

Recommended suppliersmore

  • Product
  • FOB Price
  • Min.Order
  • Supply Ability
  • Supplier
  • Contact Supplier

1482-51-5 Usage

Check Digit Verification of cas no

The CAS Registry Mumber 1482-51-5 includes 7 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 4 digits, 1,4,8 and 2 respectively; the second part has 2 digits, 5 and 1 respectively.
Calculate Digit Verification of CAS Registry Number 1482-51:
(6*1)+(5*4)+(4*8)+(3*2)+(2*5)+(1*1)=75
75 % 10 = 5
So 1482-51-5 is a valid CAS Registry Number.

1482-51-5SDS

SAFETY DATA SHEETS

According to Globally Harmonized System of Classification and Labelling of Chemicals (GHS) - Sixth revised edition

Version: 1.0

Creation Date: Aug 20, 2017

Revision Date: Aug 20, 2017

1.Identification

1.1 GHS Product identifier

Product name (5α)-17,21-Dihydroxypregnane-3,11,20-trione

1.2 Other means of identification

Product number -
Other names BETAPAR

1.3 Recommended use of the chemical and restrictions on use

Identified uses For industry use only.
Uses advised against no data available

1.4 Supplier's details

1.5 Emergency phone number

Emergency phone number -
Service hours Monday to Friday, 9am-5pm (Standard time zone: UTC/GMT +8 hours).

More Details:1482-51-5 SDS

1482-51-5Relevant articles and documents

The effect of disease associated point mutations on 5β-reductase (AKR1D1) enzyme function

Mindnich, Rebekka,Drury, Jason E.,Penning, Trevor M.

scheme or table, p. 250 - 254 (2012/03/26)

The stereospecific 5β-reduction of Δ4-3-ketosterols is very difficult to achieve chemically and introduces a 90° bend between ring A and B of the planar steroid. In mammals, the reaction is catalyzed by steroid 5β-reductase, a member of the aldo-keto reductase (AKR) family. The human enzyme, AKR1D1, plays an essential role in bile-acid biosynthesis since the 5β-configuration is required for the emulsifying properties of bile. Deficient 5β-reductase activity can lead to cholestasis and neo-natal liver failure and is often lethal if it remains untreated. In five patients with 5β-reductase deficiency, sequencing revealed individual, non-synonymous point mutations in the AKR1D1 gene: L106F, P133R, G223E, P198L and R261C. However, mapping these mutations to the AKR1D1 crystal structure failed to reveal any obvious involvement in substrate or cofactor binding or catalytic mechanism, and it remained unclear whether these mutations could be causal for the observed disease. We analyzed the positions of the reported mutations and found that they reside in highly conserved portions of AKR1D1 and hypothesized that they would likely lead to changes in protein folding, and hence enzyme activity. Attempts to purify the mutant enzymes for further characterization by over-expression in Escherichia coli yielded sufficient amounts of only one mutant (P133R). This enzyme exhibited reduced Km and kcat values with the bile acid intermediate Δ4-cholesten-7α- ol-3-one as substrate reminiscent of uncompetitive inhibition. In addition, P133R displayed no change in cofactor affinity but was more thermolabile as judged by CD-spectroscopy. When all AKR1D1 mutants were expressed in HEK 293 cells, protein expression levels and enzyme activity were dramatically reduced. Furthermore, cycloheximide treatment revealed decreased stability of several of the mutants compared to wild type. Our data show, that all five mutations identified in patients with functional bile acid deficiency strongly affected AKR1D1 enzyme functionality and therefore may be causal for this disease.

REDUCTIONS MICROBIOLOGIQUES STEREOSELECTIVES DES Δ-4 CETO-3 STEROIDES

Fauve, A.,Kergomard, A.

, p. 899 - 901 (2007/10/02)

In anaerobic conditions the reduction of Δ-4 3-keto steroids by Clostridium paraputrificum leads either to the 3-keto 5β compounds or to the corresponding 3α-hydroxytetrahydro-5β derivatives.This stereospecific bioconversion of αβ-unsaturated 3-keto steroids is shown to be directed by the substrate concentration.The conversion of Δ-4 cholestenone to coprostanone or coprostanol is not observed.

Post a RFQ

Enter 15 to 2000 letters.Word count: 0 letters

Attach files(File Format: Jpeg, Jpg, Gif, Png, PDF, PPT, Zip, Rar,Word or Excel Maximum File Size: 3MB)

1

What can I do for you?
Get Best Price

Get Best Price for 1482-51-5